Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · HR 6434

Freedom to Heal Act of 2025

Refreshed 2 h ago

Introduced 2025-12-04Topic: health care

Summary

AI-generated summary, report an error

This bill would create a special federal registration that lets physicians directly give Schedule I investigational drugs to eligible patients under the federal Right to Try law. Physicians would apply to the Attorney General with proof of an existing controlled-substance registration, a supply agreement from the drug maker, state-law permission, relevant training, and a description of the storage and treatment site. The Attorney General would have 45 days to either register the physician or issue an order to show cause. Physicians could only hold the drug amounts listed in their application or in a supplemental notice, which would be approved after 30 days unless challenged. The Attorney General would issue an interim rule within 240 days and a final rule within 2 years after that.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2025-12-04HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.refer
2025-12-04HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.refer
2025-12-04Introduced in Houseintroduce
2025-12-04Introduced in Houseintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-10-10. Provisions and opinion polling arrive in a later release.